相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
A. Zaanan et al.
ANNALS OF ONCOLOGY (2010)
Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?
Sergio Rizzo et al.
CANCER TREATMENT REVIEWS (2010)
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer
J. Souglakos et al.
BRITISH JOURNAL OF CANCER (2009)
PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
Andrea Sartore-Bianchi et al.
CANCER RESEARCH (2009)
Diagnostic Standards in the Pathology of Inflammatory Bowel Disease
Christoph Loddenkemper
DIGESTIVE DISEASES (2009)
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
Monica M. Bertagnolli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Venous invasion detection in colorectal cancer: which approach, which technique?
G. Puppa et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Thymidylate synthase gene variations: predictive and prognostic markers
Georg Lurje et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Endoscopic and pathological aspects of colitis-associated dysplasia
Fiona D. M. van Schaik et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Significance of signet-ring cells in patients with colorectal cancer
Rashmi Pande et al.
DISEASES OF THE COLON & RECTUM (2008)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Predictive biomarkers of chemotherapy efficacy in colorectal cancer: Results from the UK MRC FOCUS trial
Michael S. Braun et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Entwicklung molekularpathologischer Entitäten beim Dickdarmkarzinom
T. Kirchner et al.
PATHOLOGE (2008)
Cancer in inflammatory bowel disease
Jianlin Xie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab
Andrea Sartore-Bianchi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab
Shirin Khambata-Ford et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis
Bisong Haupt et al.
MODERN PATHOLOGY (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Cancer surveillance in inflammatory bowel disease: new molecular approaches
Rosa Ana Risques et al.
CURRENT OPINION IN GASTROENTEROLOGY (2006)
Invasive colorectal micropapillary carcinoma: an aggressive variant of adenocarcinoma
Mi-Jung Kim et al.
HUMAN PATHOLOGY (2006)
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lièvre et al.
CANCER RESEARCH (2006)
Molecular profiling of ulcerative colitis-associated neoplastic progression
DW Colliver et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Primary invasive micropapillary carcinoma of the colon
K Sakamoto et al.
HISTOPATHOLOGY (2005)
Cancer surveillance in ulcerative colitis
WM Chambers et al.
BRITISH JOURNAL OF SURGERY (2005)
Phenotype of microsatellite-stable colorectal carcinomas with CpG island methylation
LR Chirieac et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization
DE Aust et al.
HUMAN PATHOLOGY (2000)